MARKET

PRGO

PRGO

Perrigo Company
NYSE

Real-time Quotes | Nasdaq Last Sale

47.73
0.00
0.00%
Closed 16:57 06/14 EDT
OPEN
47.52
PREV CLOSE
47.73
HIGH
48.06
LOW
47.40
VOLUME
1.25M
TURNOVER
--
52 WEEK HIGH
58.83
52 WEEK LOW
38.20
MARKET CAP
6.37B
P/E (TTM)
-24.3198
1D
5D
1M
3M
1Y
5Y
Perrigo Co. PLC stock falls Friday, underperforms market
marketwatch.com · 3d ago
Keloid Treatment Market Share, Trends | Industry Overview 2021 to 2026
Global Keloid Treatment Market is segmented based on the treatments type as, Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional Corticosteroid Injection and Others. The report...
Heraldkeepers · 3d ago
Perrigo Co. PLC stock rises Thursday, outperforms market
marketwatch.com · 4d ago
Perrigo (PRGO) Up 2.9% Since Last Earnings Report: Can It Continue?
Zacks.com · 4d ago
Perrigo Co. PLC stock outperforms market on strong trading day
marketwatch.com · 6d ago
Perrigo Co PLC Stock Is Estimated To Be Fairly Valued
GuruFocus News · 06/06 15:00
Have Insiders Been Buying Perrigo Company plc (NYSE:PRGO) Shares This Year?
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
Simply Wall St. · 06/03 09:58
Perrigo Co. PLC stock falls Thursday, underperforms market
Shares of Perrigo Co. PLC slipped 1.95% to $45.82 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...
marketwatch.com · 05/27 21:17
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PRGO. Analyze the recent business situations of Perrigo Company through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 9 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PRGO stock price target is 54.13 with a high estimate of 70.00 and a low estimate of 45.00.
EPS
Institutional Holdings
Institutions: 489
Institutional Holdings: 135.74M
% Owned: 101.64%
Shares Outstanding: 133.55M
TypeInstitutionsShares
Increased
98
15.83M
New
44
2.47M
Decreased
126
14.31M
Sold Out
64
1.74M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.15%
Pharmaceuticals & Medical Research
+0.13%
Key Executives
Non-Executive Chairman/Independent Director
Rolf Classon
President/Chief Executive Officer/Director
Murray Kessler
Chief Financial Officer/Executive Vice President
Raymond Silcock
Chief Human Resource Officer/Executive Vice President
Robert Willis
Executive Vice President/Chief Information Officer
Thomas Farrington
Executive Vice President/Chief Scientific Officer
James Dillard
Executive Vice President/General Counsel/Secretary
Todd Kingma
Executive Vice President/General Manager
Richard Sorota
Executive Vice President
Svend Andersen
Executive Vice President
Ronald Janish
Executive Vice President
Sharon Kochan
Executive Vice President
Rich Sorota
Executive Vice President
Grainne Quinn
Independent Director
Bradley Alford
Independent Director
Orlando Ashford
Independent Director
Katherine Doyle
Independent Director
Adriana Karaboutis
Independent Director
Jeffrey Kindler
Independent Director
Erica Mann
Independent Director
Donal O'Connor
Independent Director
Geoffrey Parker
Independent Director
Theodore Samuels
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 0.24
06/03/2021
02/23/2021
Dividend USD 0.24
03/11/2021
10/22/2020
Dividend USD 0.225
11/25/2020
07/29/2020
Dividend USD 0.225
08/27/2020
05/05/2020
Dividend USD 0.225
05/28/2020
02/18/2020
Dividend USD 0.225
02/27/2020
11/04/2019
Dividend USD 0.21
11/27/2019
07/31/2019
Dividend USD 0.21
08/29/2019
04/26/2019
Dividend USD 0.21
05/30/2019
02/14/2019
Dividend USD 0.19
02/28/2019
10/31/2018
Dividend USD 0.19
11/29/2018
08/01/2018
Dividend USD 0.19
08/30/2018
05/03/2018
Dividend USD 0.19
05/31/2018
02/15/2018
Dividend USD 0.19
03/01/2018
11/02/2017
Dividend USD 0.16
11/30/2017
08/08/2017
Dividend USD 0.16
08/23/2017
05/03/2017
Dividend USD 0.16
05/24/2017
02/21/2017
Dividend USD 0.16
03/01/2017
11/08/2016
Dividend USD 0.145
11/22/2016
08/02/2016
Dividend USD 0.145
08/24/2016
  • All
  • Financials
  • Insiders
More
About PRGO
Perrigo Co. Plc engages in providing over-the-counter (OTC) self-care and wellness solutions. Its solutions enhance individual well-being by enabling consumers to proactively prevent or treat conditions that can be self-managed. The Company operates through three segments: Consumer Self-Care Americas, Consumer Self-Care International and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the store brand consumer self-care business in the United States (U.S.), Mexico and Canada. The Consumer Self-Care International segment includes the branded consumer self-care business in Europe, along with generic consumer-focused businesses in the United Kingdom (U.K.) and Australia. The Prescription Pharmaceuticals segment commercializes and manufactures generic prescription products in the U.S. and diagnostic products in Israel.

Webull offers kinds of Perrigo Company PLC stock information, including NYSE:PRGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PRGO stock methods without spending real money on the virtual paper trading platform.